Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
about
CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infectionContribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signatureSoluble CD27-pool in humans may contribute to T cell activation and tumor immunity.Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markersReduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative AdultsImmune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques.Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapySoluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).HIV-associated memory B cell perturbations.Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D.Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.Soluble CD27 induces IgG production through activation of antigen-primed B cells.Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.
P2860
Q33438469-6B0D7896-5E4A-4DC8-9217-099FAD0945B7Q33599291-5874AD1A-87AE-4669-BC8A-6441A32D3C8FQ33855420-4E6892AD-F19F-42AA-B017-1D7E2E7C3156Q34094968-120584C3-B688-4844-B3CD-66ACB3A9DD56Q35174468-DE851303-AAA8-4CB7-BB28-F320F33A0BA1Q35878906-40E26214-8BCD-489D-86C1-E6E3E7B543ECQ35940864-DDA80265-1435-413E-912F-56E29D6ADF99Q36199763-88690C50-8C6B-4DFD-ACDA-0D667E4690C2Q36397469-9FFFCE9E-CF15-4640-9E4B-DB730D46B761Q36512579-13B40A48-010F-486C-BD86-68457983CBC0Q36983335-8FF0DD7C-8B41-4FF6-8124-8E32A69E1BDDQ37704680-F7295FDA-1733-479B-AF5C-26CECC9F262CQ38426638-F8B4BE34-68FD-4962-8DBF-83373C4DC675Q47236316-B06DEFD0-4458-417F-A2A1-FBB5D87B2C8FQ49902642-AAC245D9-624F-4AA6-AA2D-1BB6D7945520Q50992637-C4A7C226-3BEA-4AD4-B7AB-52A473AE85A5Q52672845-453B1FA6-B234-4AB8-ADAD-7CD64A2758BAQ55139939-A59F8017-EB69-4E43-B3A3-CBBBAC52C35A
P2860
Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@en
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@nl
type
label
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@en
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@nl
prefLabel
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@en
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@nl
P2093
P2860
P1476
Plasma levels of soluble CD27: ...... py in HIV-1-infected subjects.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2002.01786.X
P577
2002-03-01T00:00:00Z